Release Date: 28/10/16 14:23 Summary: Quarterly Activities Report and Quarterly Cashflow Report-SMC.AX Price Sensitive: Yes Download Document 1.89MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%